Armed with a solid understanding of study design strategies and issues in interpretation, managed care pharmacists can proceed into the wealth of health care information, confident in their assessments of the validity and utility of research findings.
design strategies and their advantages, disadvantages, and appropriateness for certain research subjects, as wel1 as a review of issues in interpretation, including the roles of bias and confounding.
For the purposes of this discussion, unless othenvise noted, the term disease refers to a deviation from normal human functioning (e.g., congestive heart failure) or other outcomes of interest (e.g., myocardial infarction). The term exposure refers to a risk factor for developing a particular disease (e.g., high-fat diet) or to a measure taken to improve or prevent a disease or event (medication, exercise).
ASSESSING DESIGN STRATEGIES
In eva1uating a study, the key question to ask is whether the design employed in the study fits the subject." As shown in Table 2 Analytic studies can be differentiated by the ro1e the investigator plays in assigning the exposure. When the exposure is control1ed by the investigator, the study is an experimenta1 study, e.g., a c1inica1 trial in which allotment of the exposure (i.e., the treatment) is prospectively determined. When the investigator does not control assignment of the exposure, the study is considered an observational study. 
